Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 111014016 | 11101401 | 6 | F | 2012 | 20160729 | 20150508 | 20160804 | EXP | US-PFIZER INC-2015152217 | PFIZER | 70.00 | YR | F | Y | 87.00000 | KG | 20160804 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 111014016 | 11101401 | 1 | PS | LYRICA | PREGABALIN | 1 | Oral | 150 MG, 3X/DAY | L91501 | 21446 | 150 | MG | CAPSULE, HARD | TID | |||||
| 111014016 | 11101401 | 2 | SS | LYRICA | PREGABALIN | 1 | 21446 | CAPSULE, HARD | |||||||||||
| 111014016 | 11101401 | 3 | SS | SUTENT | SUNITINIB MALATE | 1 | Oral | 25 MG, CYCLIC (ON 28 DAYS, THEN OFF FOR 2 WEEKS) | Z615B | 21938 | 25 | MG | CAPSULE, HARD | ||||||
| 111014016 | 11101401 | 4 | SS | SUTENT | SUNITINIB MALATE | 1 | 21938 | CAPSULE, HARD | |||||||||||
| 111014016 | 11101401 | 5 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | Oral | 10 MG, 1X/DAY (ONE IN THE MORNING BY MOUTH) | 0 | 10 | MG | TABLET | QD | ||||||
| 111014016 | 11101401 | 6 | C | GLYBURIDE. | GLYBURIDE | 1 | Oral | 1 DF, UNK (2.5/500MG ONE BY MOUTH) | 0 | 1 | DF | ||||||||
| 111014016 | 11101401 | 7 | C | DOXAZOSIN | DOXAZOSINDOXAZOSIN MESYLATE | 1 | Oral | 4 MG, 1X/DAY | 0 | 4 | MG | TABLET | QD | ||||||
| 111014016 | 11101401 | 8 | C | XARELTO | RIVAROXABAN | 1 | Oral | 15 MG, 1X/DAY | 0 | 15 | MG | TABLET | QD | ||||||
| 111014016 | 11101401 | 9 | C | ZANTAC | RANITIDINE HYDROCHLORIDE | 1 | Oral | 300 MG, 2X/DAY | 0 | 300 | MG | TABLET | BID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 111014016 | 11101401 | 1 | Fibromyalgia |
| 111014016 | 11101401 | 2 | Neuropathy peripheral |
| 111014016 | 11101401 | 3 | Renal cell carcinoma |
| 111014016 | 11101401 | 4 | Colon cancer |
| 111014016 | 11101401 | 5 | Hypertension |
| 111014016 | 11101401 | 6 | Diabetes mellitus |
| 111014016 | 11101401 | 7 | Hypertension |
| 111014016 | 11101401 | 8 | Anticoagulant therapy |
| 111014016 | 11101401 | 9 | Dyspepsia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 111014016 | 11101401 | OT |
| 111014016 | 11101401 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 111014016 | 11101401 | Amnesia | |
| 111014016 | 11101401 | Arthralgia | |
| 111014016 | 11101401 | Colon cancer recurrent | |
| 111014016 | 11101401 | Depression | |
| 111014016 | 11101401 | Disease recurrence | |
| 111014016 | 11101401 | Gait disturbance | |
| 111014016 | 11101401 | Nausea | |
| 111014016 | 11101401 | Pain | |
| 111014016 | 11101401 | Panic attack | |
| 111014016 | 11101401 | Pneumonia | |
| 111014016 | 11101401 | Pulmonary thrombosis | |
| 111014016 | 11101401 | Renal cancer recurrent | |
| 111014016 | 11101401 | Weight increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 111014016 | 11101401 | 1 | 2009 | 0 | ||
| 111014016 | 11101401 | 3 | 2013 | 0 |